Mastectomy for Breast Cancer: 631 Real Stories

631 stories match breast cancer and mastectomy. 611 of them mention surgery.

Cancer Stories

A patient, who was diagnosed with Invasive Ductal CarcinomaBreast Cancer

Breast Cancer Recurrence Treated With Radiation Despite a Chronic Skin Condition

Patient Info: Anonymized, Female, 50s

Biomarkers: ER-positive; PR-positive; HER2-negative

After treatment of a chest-wall recurrence and a radiographically suspicious ischial lesion, she completed chest-wall radiation, her skin healed within 5 weeks, and she remained under surgical, radiation-oncology, and dermatology review.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

HER2-positive breast cancer diagnosed during pregnancy and later spread to bone and brain

Patient Info: Anonymized, Female, Under 40 | Stage IV

Biomarkers: Initial tumour: ER 0%, PR <1%, HER2 3+

Metastatic Site: bone (L3)|brain

After treatment and surveillance without new lesions, she developed a large symptomatic occipital brain metastasis 14 months after completing paclitaxel and radiation and died after rapid neurological deterioration.

PubMed Central
OutcomeIn Memory
Allison, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Stage IV Invasive Ductal Carcinoma: Allison's Patient Story

Patient Info: Allison Rebello, female, 40s | Stage IV

Metastatic Site: bones (neck, spine, hip, ribs), lungs

As of October 2020, Allison’s metastatic breast cancer was stable and she was feeling well on daily oral cancer therapy.

Dana-Farber
OutcomeStable Disease
Pam, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Pam's Patient Story

Patient Info: Pam Benchley, Female, 50s | Stage IV

Biomarkers: Not explicitly reported; treated with anti-estrogen therapy and a CDK4/6 inhibitor

Metastatic Site: Liver

As of October 2020, Pam had responded favorably to anti-estrogen therapy plus a CDK4/6 inhibitor, surgery, radiation and liver radiofrequency ablation; her oncologist described her as free of evidence of active cancer, while avoiding the term cancer-free for metastatic disease.

Cleveland Clinic
OutcomeResponding Well
Jessica, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Triple-Negative Breast Cancer: Jessica's Survivor Story

Patient Info: Jessica Duemig, Female, Under 40 | Stage II

Biomarkers: ER-negative; PR-negative; HER2-negative

As of October 2020, Jessica had been considered cured since February 2020 after treatment for Stage IIA triple-negative metaplastic breast cancer and was described as living life to the fullest about 3 years after diagnosis.

YouTube — Baptist Health
OutcomeCancer-Free / NED
A patient, who was diagnosed with Invasive Ductal CarcinomaBreast Cancer

Triple-Negative Breast Cancer Treated With Mastectomy and Chemotherapy

Patient Info: Anonymized, Female, 40s

Biomarkers: Triple-negative.

The later accessory-breast-tissue cancer was considered a separate new primary after a five-year interval, and she was currently without evidence of disease.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Breast CancerBreast Cancer

A Rare Metaplastic Breast Cancer With Bone-Like Tissue Formation

Patient Info: Anonymized, Female, 70+

Biomarkers: ER weakly positive; PR-negative; HER2-negative; BRCA mutation not detected; described as triple-negative

One year after left mastectomy, she was alive without notable complications or evidence of recurrence.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Invasive Ductal CarcinomaBreast Cancer

HER2-Positive Breast Cancer Linked to a Rare Immune-Related Neurological Syndrome

Patient Info: Anonymized, Female, 40s

Biomarkers: HER2-positive in both foci; one focus ER-negative/PR-positive with Ki-67 45%; second focus ER-negative/PR-negative with Ki-67 35%; anti-Yo antibodies positive in serum and CSF; tumour-susceptibility gene panel negative

At 1 year, she had completed trastuzumab, continued tamoxifen, and had no evidence of recurrent breast cancer; intensive rehabilitation improved her mobility, although balance and right-sided neurological deficits persisted.

PubMed Central
OutcomeCancer-Free / NED
Doris, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Doris's Patient Story

Patient Info: Doris, Female | Stage IV

Metastatic Site: lungs

As of August 2020, Doris was living with Stage IV breast cancer metastatic to the lungs after chemotherapy and bilateral mastectomies, and the story asked for help so she could continue treatment.

YouTube (ES search)
OutcomeLiving With Cancer
A patient, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Recurrent Breast Cancer With a Benign-Appearing Chest-Wall Rash

Patient Info: Anonymized, Female | Stage IV

Biomarkers: Initial tumor: ER-positive; PR-negative; HER2-negative.

Metastatic Site: mediastinal lymph nodes

She had recurrent chest-wall and mediastinal metastatic disease; a later rash biopsy showed dermatitis rather than another skin recurrence.

PubMed Central
OutcomeLiving With Cancer
A patient, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Young woman with ductal breast cancer and bleeding gastric metastases

Patient Info: Anonymized, Female, Under 40 | Stage IV

Biomarkers: ER-positive; PR-negative; HER2-negative

Metastatic Site: pancreas|liver|kidney|stomach

After rapid progression to the pancreas, liver, kidney and stomach, she chose palliative care and died 1 month after presenting with gastrointestinal bleeding.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Lobular breast cancer later spread to the stomach, bone, neck and mediastinum

Patient Info: Anonymized, Female, 70+ | Stage IV

Biomarkers: ER-positive; PR-positive; HER2-negative

Metastatic Site: stomach|bone|neck|mediastinum

After gastric metastasis was diagnosed and later imaging showed bone, neck and mediastinal spread, her oral intake and health declined; she chose palliative care and died 7 months after the diagnostic endoscopy.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Lobular Breast Cancer Spread Into a Nasal Tumor

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: Metastatic lobular focus: ER 8/8; PR 8/8; HER2-negative; E-cadherin-negative.

Metastatic Site: liver; bone; right nasal cavity within an olfactory…

The nasal lesion was removed with no residual local disease on imaging, and capecitabine was restarted while oncology follow-up continued for metastatic breast cancer.

PubMed Central
OutcomeCare Ongoing
Kristine, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Stage IV Invasive Ductal Carcinoma: Kristine's Patient Story

Patient Info: Kristine, Female | Stage IV

Metastatic Site: Lymph nodes; chest wall; upper lungs

As of May 2020, Kristine was living with recurrent metastatic breast cancer involving lymph nodes, chest wall and upper lungs, after surgery and radiation, with daily oral chemotherapy helping keep cancer controlled.

Cleveland Clinic
OutcomeLiving With Cancer